Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania

Author:

Nyabakari Cecilia J1,Mori Amani Thomas1

Affiliation:

1. Muhimbili University of Health and Allied Sciences

Abstract

Abstract Background Most cervical cancer patients in developing countries present in health facilities with an advanced disease, characterized by obstructive uropathy. This study aims to estimate the cost of an image-guided percutaneous nephrostomy (PCN), which was recently introduced at Muhimbili National Hospital to manage obstructive uropathy. Methods This was a cross-sectional study that was conducted between February and June 2021, from the provider's perspective. The study used a micro-costing approach to identify, quantify and value both capital and recurrent items consumed in the provision of services. Cost data were collected in Tanzanian shillings and converted to USD. Analysis was performed in an Excel spreadsheet (Microsoft Excel®, Microsoft Corporation). Results The estimated cost of image-guided PCN at Muhimbili National Hospital was 358.6 USD per patient. The main cost drivers were the cost of materials and supplies particularly the single-use Nephrostomy catheters, Amplatz guide wire, and Micro-puncture set. The estimated unit cost from this study is higher than the reimbursement price of 237.4 USD charged by the National Health Insurance Fund, and the 259.40 USD and 172.9 USD charged by the hospital for private and public patients, respectively. Conclusion Image-guided PCN for cervical patients is a relatively expensive procedure for a typical patient without health insurance. The study further underscores the importance of conducting costing studies to inform pricing and reimbursement decisions.

Publisher

Research Square Platform LLC

Reference23 articles.

1. WHO. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva: World Health Organization; 2014.

2. Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. Human Papillomavirus and Related Diseases in the World. Summary Report 22 October 2021. Barcelona: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre).

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

4. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020.

5. WHO. Costing the National Response to Cervical Cancer: United Republic of Tanzania, 2020–2024. Dar es Salaam: The World Health Organization; 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3